The antiscalants/scale inhibitors market was valued at $3.5 billion in 2022 and is estimated to reach $5.5 billion by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032.
Allied Market Research published a report, titled, “Antiscalants/Scale Inhibitors Market By Type (Carboxylate, Sulfonates, Phosphonates, Fluorids, and Others), By Method (Threshold Inhibition,...
English
العربية
Français
Español
Português
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt